Sargent Bickham Lagudis’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$21.7K Hold
107
﹤0.01% 588
2022
Q3
$19K Sell
107
-4
-4% -$819 ﹤0.01% 579
2022
Q2
$22K Buy
+111
New +$23.7K ﹤0.01% 573
2020
Q3
Sell
-70
Closed -$10K 815
2020
Q2
$10K Hold
70
﹤0.01% 581
2020
Q1
$8K Hold
70
﹤0.01% 589
2019
Q4
$10K Sell
70
-29
-29% -$4.19K ﹤0.01% 613
2019
Q3
$14K Hold
99
﹤0.01% 527
2019
Q2
$15K Hold
99
﹤0.01% 537
2019
Q1
$13K Sell
99
-7,926
-99% -$976K ﹤0.01% 573
2018
Q4
$871K Sell
8,025
-543
-6% -$72.7K 0.11% 117
2018
Q3
$1.28M Buy
+8,568
New +$1.3M 0.15% 109
2018
Q2
Sell
-30
Closed -$4K 778
2018
Q1
$4K Hold
30
﹤0.01% 681
2017
Q4
$4K Hold
30
﹤0.01% 704
2017
Q3
$4K Hold
30
﹤0.01% 712
2017
Q2
$4K Buy
+30
New +$3.67K ﹤0.01% 674

Other funds holding LH

Sargent Bickham Lagudis's LH Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Labcorp (LH) position steady in Q4 2022 at 107 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Sargent Bickham Lagudis first reported a position in LH in Q2 2017 and has held it in 15 quarters since. The position peaked at $1.28M in Q3 2018. 969 funds tracked by Wall St. Rank hold LH as of Q4 2022.

  • Sargent Bickham Lagudis held 107 shares of Labcorp worth $21.7K as of Q4 2022.
  • Sargent Bickham Lagudis left its Labcorp share count unchanged in Q4 2022.
  • Labcorp made up ﹤0.01% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #588 holding.
  • Sargent Bickham Lagudis first reported a position in Labcorp in Q2 2017 and has held it in 15 quarters since.
  • Sargent Bickham Lagudis's Labcorp position peaked at $1.28M in Q3 2018.
  • 969 funds tracked by Wall St. Rank held Labcorp as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.